Y-mAbs Therapeutics Statistics
Total Valuation
YMAB has a market cap or net worth of $649.65 million. The enterprise value is $572.43 million.
| Market Cap | 649.65M |
| Enterprise Value | 572.43M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, after market close.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
YMAB has 43.78 million shares outstanding. The number of shares has decreased by -0.13% in one year.
| Shares Outstanding | 43.78M |
| Shares Change (YoY) | -0.13% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 14.55% |
| Owned by Institutions (%) | 66.27% |
| Float | 25.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 119.05 |
| PS Ratio | 7.66 |
| Forward PS | 6.42 |
| PB Ratio | 6.43 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.52, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.52 |
| Quick Ratio | 5.02 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 5.34 |
Financial Efficiency
Return on equity (ROE) is -20.70% and return on invested capital (ROIC) is -25.07%.
| Return on Equity (ROE) | -20.70% |
| Return on Assets (ROA) | -16.30% |
| Return on Capital (ROIC) | -25.07% |
| Revenue Per Employee | $848,190 |
| Profits Per Employee | -$214,270 |
| Employee Count | 100 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 1.94 |
Taxes
In the past 12 months, YMAB has paid $561,000 in taxes.
| Income Tax | 561,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +156.75% in the last 52 weeks. The beta is 0.76, so YMAB's price volatility has been lower than the market average.
| Beta (1Y) | 0.76 |
| 52-Week Price Change | +156.75% |
| 50-Day Moving Average | 15.74 |
| 200-Day Moving Average | 8.98 |
| Relative Strength Index (RSI) | 47.36 |
| Average Volume (30 Days) | 400,991 |
Short Selling Information
The latest short interest is 2.33 million, so 5.32% of the outstanding shares have been sold short.
| Short Interest | 2.33M |
| Short Previous Month | 2.24M |
| Short % of Shares Out | 5.32% |
| Short % of Float | 9.18% |
| Short Ratio (days to cover) | 6.85 |
Income Statement
In the last 12 months, YMAB had revenue of $84.82 million and -$21.43 million in losses. Loss per share was -$0.49.
| Revenue | 84.82M |
| Gross Profit | 73.40M |
| Operating Income | -25.67M |
| Pretax Income | -20.87M |
| Net Income | -21.43M |
| EBITDA | -24.94M |
| EBIT | -25.67M |
| Loss Per Share | -$0.49 |
Balance Sheet
The company has $78.64 million in cash and $1.42 million in debt, giving a net cash position of $77.22 million or $1.76 per share.
| Cash & Cash Equivalents | 78.64M |
| Total Debt | 1.42M |
| Net Cash | 77.22M |
| Net Cash Per Share | $1.76 |
| Equity / Book Value | 100.99M |
| Book Value Per Share | 2.31 |
| Working Capital | 90.98M |
Cash Flow
| Operating Cash Flow | -27.23M |
| Capital Expenditures | n/a |
| Free Cash Flow | -27.23M |
| FCF Per Share | -$0.62 |
Margins
Gross margin is 86.54%, with operating and profit margins of -30.27% and -25.26%.
| Gross Margin | 86.54% |
| Operating Margin | -30.27% |
| Pretax Margin | -24.60% |
| Profit Margin | -25.26% |
| EBITDA Margin | -29.40% |
| EBIT Margin | -30.27% |
| FCF Margin | -32.11% |
Dividends & Yields
YMAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.13% |
| Shareholder Yield | 0.13% |
| Earnings Yield | -3.30% |
| FCF Yield | -4.19% |
Analyst Forecast
The average price target for YMAB is $15.86, which is 6.87% higher than the current price. The consensus rating is "Buy".
| Price Target | $15.86 |
| Price Target Difference | 6.87% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 22.48% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
YMAB has an Altman Z-Score of 10.34 and a Piotroski F-Score of 4.
| Altman Z-Score | 10.34 |
| Piotroski F-Score | 4 |